Literature DB >> 31784404

Anti-inflammatory effect of Yam Glycoprotein on lipopolysaccharide-induced acute lung injury via the NLRP3 and NF-κB/TLR4 signaling pathway.

Xiaofeng Niu1, Lulu Zang1, Wenqi Li1, Xin Xiao1, JinJin Yu1, Qing Yao1, Jinmeng Zhao1, Zhaobo Ye2, Zhen Hu2, Weifeng Li3.   

Abstract

Acute lung injury (ALI) is a common lung disease accompanied by acute and persistent pulmonary inflammatory response syndrome, which leads to alveolar epithelial cells and capillary endothelial cell damage. Yam glycoprotein, separated from traditional Chinese yam, has been shown to have anti-inflammatory and immunomodulatory effects. In this experiment, we mainly studied the therapeutic effect and mechanism of a glycoprotein on the lipopolysaccharide (LPS)-induced ALI mice. An oral glycoprotein method was used to treat the mouse ALI model induced by LPS injection in the peritoneal cavity. Afterward, we measured the wet/dry (W/D) ratio, the activity of myeloperoxidase (MPO), the oxidative index superoxide dismutase (SOD), malondialdehyde (MDA), glutathione peroxidase (GSH-PX) and the production of inflammatory cytokines interleukin-1β (IL-1β), tumour necrosis factor-α (TNF-α), and interleukin-6 (IL-6) to evaluate the effect of yam glycoprotein on lung tissue changes. We examined the protein expression of TLR4, ASC, NF-κBp65, p-NF-κBp65, Caspase-1, IκB, NLRP3, p-IκB, and β-actin by western blot analysis. Immunohistochemical analyses of NLRP3 and p-p65 in lung tissue were carried out to assess the mechanism of glycoprotein action. This result suggests that glycoprotein markedly depressed LPS-induced lung W/D ratio, MPO activity, MDA content SOD and GSH-Px depletion, and the contents of inflammatory cytokines IL-1β, IL-6, and TNF-α. Moreover, glycoprotein blocked TLR4/NF-κBp65 signaling activation and NLRP3inflammasome expression in LPS-induced ALI mice. As this particular study shows, glycoprotein has a safeguarding effects on LPS-induced ALI mice, possibly via activating NLRP3inflammasome and TLR4/NF-κB signaling pathways.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute lung injury; NF-κB signaling pathway; NLRP3inflammasome; TLR4; Yam glycoprotein

Year:  2019        PMID: 31784404     DOI: 10.1016/j.intimp.2019.106024

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  6 in total

1.  Publication trends of research on acute lung injury and acute respiration distress syndrome during 2009-2019: a 10-year bibliometric analysis.

Authors:  Chen Wang; Xuren Wang; Xisha Long; Demeng Xia; Daofeng Ben; Yin Wang
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

2.  Antipharyngitis Effects of Syringa oblata L. Ethanolic Extract in Acute Pharyngitis Rat Model and Anti-Inflammatory Effect of Ir-Idoids in LPS-Induced RAW 264.7 Cells.

Authors:  Wen-Bo Zhu; Fa-Zhi Su; Yan-Ping Sun; Bing-You Yang; Qiu-Hong Wang; Hai-Xue Kuang
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-10       Impact factor: 2.629

3.  Identification of key immune genes for sepsis-induced ARDS based on bioinformatics analysis.

Authors:  Ye Chen; Chenhui Qiu; Wanru Cai
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

4.  Carvedilol alleviates lipopolysaccharide (LPS)-induced acute lung injury by inhibiting Ras homolog family member A (RhoA)/ROCK activities.

Authors:  Jing Xu; Shipin Zhao; Li Zhao; Mengxiu Sun
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

5.  Aspirin eugenol ester alleviates lipopolysaccharide-induced acute lung injury in rats while stabilizing serum metabolites levels.

Authors:  Qi Tao; Zhen-Dong Zhang; Zhe Qin; Xi-Wang Liu; Shi-Hong Li; Li-Xia Bai; Wen-Bo Ge; Jian-Yong Li; Ya-Jun Yang
Journal:  Front Immunol       Date:  2022-07-29       Impact factor: 8.786

6.  Ginkgolide B Alleviates Learning and Memory Impairment in Rats With Vascular Dementia by Reducing Neuroinflammation via Regulating NF-κB Pathway.

Authors:  Lijuan Huang; Yijie Shi; Liang Zhao
Journal:  Front Pharmacol       Date:  2021-06-17       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.